Dr. Robert L. Grubb III, MD

Dr. Grubb practices at MUSC Physicians in Mount Pleasant, South Carolina.

Dr. Grubb's NPI, 1558388058, was assigned on July 17, 2006. Dr. Grubb graduated from Emory School of Medicine in 1996. Dr. Grubb holds South Carolina license 51820.

Dr. Grubb's primary practice is MUSC Physicians, at 1208 2 Island Ct, Mount Pleasant, SC 29466 in Charleston County. The practice phone is (803) 286-4666.

Dr. Grubb's primary practice is MUSC Physicians in Mount Pleasant, South Carolina. Dr. Grubb is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Dr. Grubb to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grubb practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Grubb's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Grubb is board certified in urology by the American Board of Urology. Dmand AI has Dr. Grubb's licenses on file in 3 states: South Carolina, Missouri and Maryland.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and kidney stone disease among the conditions Dr. Grubb treats.

CMS data shows 1,328 Medicare services from Dr. Grubb across 15 procedure codes in 2024, for 509 Medicare patients. Medicare paid $67,790 for them.

CMS counts 509 Medicare patients who saw Dr. Grubb in 2024. The largest group is 65 to 74, with 254 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Grubb's median patient age at 70, with 23% women.

In 2024, Dr. Grubb wrote 1,076 Medicare Part D claims for 244 patients. 89% of them were for generic drugs. CMS names the drug for 894 of them, across 15 drugs with 11 or more claims each, at $94,972 in total drug cost. In 2023, CMS named 828 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Grubb for performance year 2024, reported as part of a group. Dr. Grubb accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Grubb as offering telehealth. CMS counts 11 procedures of prostate resection by Dr. Grubb, more than 60% of the clinicians it reports for that procedure.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 32 papers to Dr. Grubb, published from 2009 to 2024. 2021 was the busiest year, with 4. The most frequent topics are Prostatic Neoplasms, Prostate-Specific Antigen and Early Detection of Cancer. Dr. Grubb has published most often in J Urol. Dr. Grubb's most frequent co-authors are Gerald L. Andriole, MD, Elward David Crawford, MD and Jonathan Andrew Coleman, MD.

Dmand AI links Dr. Grubb to 1 clinical trial. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 62 general payments to Dr. Grubb from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Urogen Pharma, Inc. paid the most, $664.

Dmand AI lists 2 awards for Dr. Grubb, most recently CMS Stage 1 EHR in 2012.

Dr. Grubb graduated from Emory School of Medicine in 1996. Dr. Grubb is a member of ACS and Society of Urologic Oncology.

Dr. Grubb is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.